TP53 and thymus lymphoma: Recent work showed that deletion of Akt1 in Tp53−/− mice prevents the development of thymic lymphomas (30), and thus we would expect that inhibition of PRL2 to increase PTEN protein level and attenuate Akt signaling in such a model would also hinder tumor growth.